Movement Disorders · 5 Nov 2026
Skin Seed Amplification Assay Differentiates Multiple System Atrophy from Parkinson's Disease
Anastasia Kuzkinah-index 6, Diego Rodriguez, Celine Panzer, Alain Ndayisaba, Antonia Kohl, Shreya Rai, Breelyn Gilbert, Bruno Hammerschlag, Karie Shen, Lisa Harder‐Rauschenberger, Olivia Laun, Julia Meehan, Sucika Perumalla, Elena Salabasidou, Kristie Jones, Dalina Ceku, Robert Blum, Susanne Knorr, Camelia M. Monoranu, Claudia Sommer, Jens Volkmann, Barbara K. Changizi, Kathrin Doppler, Vikram Khuranah-index 13
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Abstract Background Misdiagnoses of multiple system atrophy (MSA) and Parkinson's disease (PD) remain common. Objective The objective of the study was to develop a skin α‐synuclein seed amplification assay (αSyn‐SAA) for detecting pathological α‐synuclein and distinguishing MSA from PD. Methods In this blinded, cross‐sectional study, 308 skin biopsies from 117 participants were analyzed using a standardized thioflavin T fluorescence‐based αSyn‐SAA protocol. The cohort included 42 PD, 31 MSA, 30 controls, and 14 progressive supranuclear palsy (PSP) cases. Kinetic parameters were analyzed to differentiate PD from MSA, and matched skin cerebrospinal fluid (CSF)/magnetic resonance imaging (MRI) analyses were performed. Assay thresholds were predefined using brain lysates from neuropathologically confirmed cases. Fibril morphology from amplified skin samples was compared to postmortem brain using proteinase K digestion and electron microscopy. Results αSyn‐SAA detected synucleinopathy (PD or MSA) with 82.2% sensitivity and 90% specificity versus controls. Receiver operating characteristic (ROC) analysis showed that maximum fluorescence ( F max , area under the curve [AUC] = 0.93) and lag time (AUC = 0.91) distinguished PD from MSA at the biopsy level. SAA positivity correlated with rapid eye movement (REM) sleep behavior disorder (RBD) in both disorders. Among SAA‐positive cases, the 50% mean F max cutoff correctly classified the underlying synucleinopathy in 81.7% of cases (49 of 60). Disease‐specific kinetic and structural signatures were reproducible across laboratories and αSyn substrate batches and were supported by concordant findings in a subset of skin samples matched to CSF, MRI data, and postmortem brain tissue. Conclusion Skin αSyn‐SAA detects pathological α‐synuclein in living patients with high accuracy and distinguishes MSA from PD based on assay kinetics and fibril strain properties, supporting its potential as a biomarker to distinguish among synucleinopathies. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Vikram Khurana has the highest h-index among the authors (13).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (44)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 24 more references
A free account opens the rest of the citing papers and references on every paper’s page.